Vcaps® Enteric Capsule Technology
Vcaps® Enteric is a fully compliant capsule technology that simplifies drug enteric delivery implementation from early stage development to commercial manufacturing. Vcaps Enteric capsules have been evaluated in-vitro and in-vivo across a number of compounds, and have proven full compliance with relevant EP, JP and US Pharmacopeia monographs. By removing the need for enteric coating, Vcaps® Enteric capsules offer tremendous potential in early stage product development, greatly simplifying formulation and process development as well as scale-up and validation. Intrinsically enteric capsule technologies also provide product differentiation and life cycle management opportunities.
Contact Details:
Company name: Capsugel
Website: www.capsugel.com/biopharmaceutical-products/vcaps-enteric-capsules
E-mail: solutions.emea@capsugel.com
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
A Novel, Enhanced, and Sustainable Approach to Audit Trail Review
July 4th 2025Eli Lilly and Company developed an innovative and sustainable approach to audit trail review (ATR) aimed at reducing the ATR burden while adhering to regulatory expectations and data integrity (DI) principles. The process has transformed employees' understanding of ATR and complemented the DI by design approach, leading to better system designs that meet expected controls and reduce non-value-added data reviews.
